NCT01036087 2023-03-30
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
SCRI Development Innovations, LLC
GBG Forschungs GmbH
GBG Forschungs GmbH